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Objective: This study aimed to evaluate the safety and feasibility of total
endovascular repair of the aortic arch using a novel designed stent-graft system
(Yanger stent-graft system; Lifetech Scientific, Shenzhen, China) in vitro and in
a canine model.
Methods: The Yanger stent-graft system is composed of a main stent-graft,
branched stent-graft, and a delivery system. In an in vitro aortic arch simulation
test bench, the system was tested, and the success rate of stent-graft releasing,
anchoring, and positioning was recorded and analyzed. Meanwhile, in vivo
implantation of the Yanger stent-graft system was carried out in 16 healthy adult
crossbreed dogs. The feasibility of using these stent-grafts was evaluated with
aortography, multislice computed tomography, and autopsy 6 months after the
procedure.
Results: All stent-graft releasing and positioning were successful for in vitro test.
In the canine model, the Yanger stent-graft system was placed successfully in the
aortic arch in all 14 dogs with the exception of 2 mortalities. All dogs survived for
at least 3 months with normal physiologic signs. Aortography, multislice
computed tomography, and animal necropsy revealed good fixation in all cases.
The ascending aorta, descending aorta, brachiocephalic trunk, and left subclavian
artery were all covered without endoleak. There was no significant obstruction or
stenosis in brachiocephalic branches at the 6-month follow-up.
Conclusions: Total endovascular repair of aortic arch with the novel designed
Yanger stent-graft system is safe and feasible in preclinical studies. With a better
understanding of preclinical knowledge, patient selection criteria and first-in-
human studies will be addressed. (J Thorac Cardiovasc Surg 2016;151:1203-12)From the Departments of aCardiovascular Surgery and bAnesthesiology, Xijing
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The Journal of Thoracic and Cardiovascular SurgTotal endovascular aortic arch replacement is suc-
cessful in a canine model.Central Message
Total endovascular repair of the aortic arch is
safe and feasible in preclinical studies.Perspective
Total endovascular repair of the aortic arch with
the novel designed Yanger stent-graft system
is safe and feasible in preclinical studies.
With increasing preclinical knowledge, patient
selection criteria and first-in-human studies
will be addressed.See Editorial Commentary page 1213.Video clip is available online.E
TAortic diseases (aneurysm and dissection) involving the
aortic arch are usually associated with high rates of mortality
and morbidity and remain a surgical challenge.1 Various ap-
proaches have been used to treat aortic disease, including
thoracic endovascular aortic repair (TEVAR) via the chimney
technique, hybrid debranching techniques, total arch
replacement, and frozen elephant trunk operations.2-7 These
techniques require the use of cardiopulmonary bypass, deep
hypothermic circulatory arrest, or sternotomy, which is
associated with massive trauma and complications.8-11 Total
endovascular aortic arch replacement without open surgery
is challenging for cardiothoracic surgeons, cardiologists,
vascular surgeons, and interventionists. There are a limited
number of reports in the literature regarding total
endovascular aortic arch replacement.12,13 We have
developed a new stent-graft system designed for total
endovascular arch replacement and have included its pre-
clinical in vitro testing and animal study results in this article.ery c Volume 151, Number 4 1203
Abbreviations and Acronyms
BCT ¼ brachiocephalic trunk
LSCA ¼ left subclavian artery
MSCT ¼ multislice computed tomography
TEVAR ¼ thoracic endovascular aortic repair
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TMATERIALS AND METHODS
Description of the Stent-Graft System
The Yanger stent-graft system (Lifetech Scientific, Shenzhen, China) is
composed of 3 parts: the primary stent-graft, branched stent-graft, and
delivery system. The primary stent-graft is based on the Ankura II
stent-graft system (Lifetech Scientific). However, the Yanger stent-graft
system consists of a native branch and 1 or 2 in situ fenestrations
(Figure 1, A and B). The diameter of the fenestration and the distance
between the fenestration and the branch graft are predetermined and may
be modified for individual patients. The use of a polytetrafluoroethylene
and nitinol frame affords the primary stent-graft excellent flexibility and
allows for modifications to the curvature of the aortic arch. The branched
stent-graft is a derby hat–shaped short stent-graft and is composed of a
polytetrafluoroethylene and nitinol frame (Figure 1, C and D). With the
use of a delivery system (Figure 1, E and F), the branched stent-graft
may be inserted into the fenestrations of the primary stent-graft. The derby
hat–shaped branched stent-graft is designed to reduce the risk of leakage
between the fenestrations of the primary stent-graft and the branched
stent-graft. The Yanger stent-graft system is designed to mimic the
anatomy of a native aortic arch (Figure 1,G andH). Because animalmodels
possess only 2 super-aortic branches, we have designed a stent-graft with 1
branch and 1 fenestration for the animal study (Figure 1, I and J).
Three Yanger stent-graft systems (24-20-160 mm, 28-24-160 mm, and
32-26-160 mm) were manufactured for the in vitro testing and the animal
studies. Both fenestrations were 15 mm in diameter, and the distances
between the fenestrations and the branch were predetermined as 8 mm.
During the animal testing, the length of the covered stent-graft was
40 mm. The diameters of the proximal and distal stents, as well as the
branch, fenestrations, and distances between the fenestrations and the
branch, may be individualized. The sheath is 23F for the 24-mm and
28-mm systems and 24F for the 32-mm main stent-graft system. This
sheath is a commercially available sheath that is used in Ankura thoracic
stent-graft products and is also from LifeTech Scientific.
Release Procedure
The release procedure of the Yanger stent-graft system was performed
as follows: Laparoscopy was performed to expose and cannulate the
abdominal aorta. The brachiocephalic trunk (BCT) was punctured and
inserted with a 6F sheath. Through the sheath, a 6F multipurpose catheter
with slippery wire was advanced into the abdominal aorta and femoral
artery. By making a purse suture of the abdominal aorta, the 6F
multipurpose catheter was taken out and the branch traction wire of the
primary stent-graft was inserted into the catheter and all along the route
out of the BCT. A Lunderquist super-stiff guidewire (Cook Inc,
Bloomington, Ind) was advanced from the abdominal or femoral artery
into the ascending aorta and left ventricle. By using the Lunderquist
guidewire, the delivery system and compressed primary stent-graft were
advanced into the aortic arch (Figure 2, A). The branch stent-graft of the
main graft system is first compressed into a small sheath with a retracting
wire inside. By stretching the branch traction wire, simultaneously
advancing the primary stent-graft delivery system, and gradually retracting
the outer sheath of the delivery system, the compressed branch was guided
to the orifice of the BCT and in the desired position (Figure 2, B). By
releasing the outer sheath, the distal portion of the stent-graft was opened1204 The Journal of Thoracic and Cardiovascular Sur(Figure 2, C). By retracting the guidewire through the BCT, the branch of
the primary stent-graft was released (Figure 2, D). The safety locker of the
delivery system was released, and the front fixation of the primary
stent-graft was opened and positioned (Figure 2, E). After full deployment
of the primary stent-graft, the delivery sheath was retrieved (Figure 2, F). A
super-slippery wire/stiff-wire was introduced into the left subclavian artery
(LSCA) through the premade fenestration and advanced toward the orifice
of LSCA (Figure 2, G). With the use of the super-stiff guidewire, the
delivery system of the derby hat branched stent-graft was advanced into
the LSCA (Figure 2, H). After retrieving the outer sheath and retracting
the prebonded thread (Figure 2, I and J), the branched stent-graft was
released (Figure 2, K). After the retrieval of the delivery system, the
procedure was complete (Figure 2, L).
In Vitro Test
The Yanger stent-graft system was tested using an in vitro aortic arch
simulation test bench (Lifetech Scientific). The simulation test bench
was a polyurethane aortic arch model equipped with an ascending aorta,
a descending aorta, and 3 brachiocephalic branches, simulating the
anatomy of the human aortic arch. By using the simulation test bench,
the Yanger stent-graft delivery system was inserted, and the stent-graft
was subsequently released (Figure 3, A-D); the branched stent-graft was
subsequently inserted into the fenestrations of the primary stent-graft and
released (Figure 3, E-H). The success rate of the stent-graft’s release,
anchoring, and positioning was recorded and analyzed.
Preparation of Animals
Sixteen healthy adult crossbreed dogs (7 female and 9 male) weighing
an average of 28.2  2.7 kg were used in this study. Preoperative color
echocardiographic examinations were performed, and no abnormalities
were found. The skin of the neck, abdomen, and both groins was depilated
and sterilized using iodophors. All animals were intubated and ventilated
using an animal anesthesia ventilator (Matrx 3000;Midmark Corp, Dayton,
Ohio). The animals were anaesthetized via intramuscular injections of ke-
tamine (10 mg/kg of body weight) and vecuronium bromide (2 mg). Propo-
fol (0.1 mg/kg/min) was administered intravenously to maintain
anesthesia. All procedures were performed with the animals in the dorsal
recumbent position. Electrocardiogram readings were monitored
throughout the procedure.
Ethics Statement
All animals received humane care in compliance with the Ministry of
Science and Technology of the People’s Republic of China Guide for
the Care and Use of Laboratory Animals. Both the Institutional
Animal Care and Use Committee and the Medical Ethics Committee of
Xijing Hospital approved this study and each of its experiments
(20120216-4).
Total Endovascular Stent-Graft Implantation in the
Aortic Arch
Catheterization was performed in a specialized animal catheterization
laboratory. After experimental animals were fully anesthetized, carotid
and femoral/abdominal arteries were mobilized and cannulated. A 6F
pigtail catheter was advanced in the ascending aorta, and aortography
was performed. After measuring the aortic arch, the pigtail catheter was
exchanged for a Lunderquist super-stiff wire. A multipurpose catheter
and a 260-mm super slippery wire were introduced into the descending
aorta through right carotid artery cannulation, grasped, and pulled through
a femoral or an abdominal artery cannulation. By using the multipurpose
catheter, the branch wire of the primary stent-graft was introduced. With
the use of the Lunderquist super-stiff wire, the entire primary stent-graft
system was advanced into the aortic arch. The primary and branch stent-
graft systems were deployed as previously described. After the deploymentgery c April 2016
FIGURE 1. Components of the Yanger stent-graft system (Lifetech Scientific, Shenzhen, China). A, Lateral view of the primary stent-graft. B, Frontal view
of the primary stent-graft. C, Lateral view of the branched stent-graft. D, Frontal view of the branched stent-graft. E, Delivery system of the primary
stent-graft. F, Delivery system of the branched stent-graft. G, Lateral view of the final Yanger stent-graft system. H, Cross-section of the final Yanger
stent-graft system. I, Lateral view of primary stent-graft with 1 branch and 1 fenestration designed for the animal study. J, Lateral view of the final Yanger
stent-graft system with 2 branches for the animal study. The red arrow denotes the native branch, and the yellow arrow denotes the in situ fenestrations.
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FIGURE 2. Schematic illustrations of the release procedure of Yanger stent-graft system. A, Both the delivery system and the compressed primary
stent-graft were advanced into the aortic arch. B, The compressed branch was retracted into the BCT. C, The distal portion of the primary stent-graft
was opened. D, The branch of the primary stent-graft was released. E, The front fixation of the primary stent-graft was opened. F, The delivery sheath
of the primary stent-graft was retrieved. G, A super-slippery wire/stiff-wire was introduced into the LSCA. H, The delivery system of the derby hat
branched stent-graft was advanced into the LSCA. I, The outer sheath was retrieved. J, The prebonded thread was retracted. K, The branched stent-graft
was released. L, Total endovascular aortic arch reconstruction was complete.
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Tof the primary stent-graft, ascending aorta angiography was performed to
determine if an obstruction was present in the BCT or LSCA (Figure 4,
E). By using a multipurpose catheter, a super-slippery wire was introduced
into the LSCA through a premade fenestration adjacent to the orifice of
LSCA and exchanged for Lunderquist super-stiff wire (Figure 4, F).
With the Lunderquist wire, the delivery system of the derby hat branched
stent-graft was advanced into the LSCA (Figure 4, G). After retrieving
the outer sheath and retracting the prebonded thread, the branched
stent-graft was released (Figure 4, H). By retrieving the delivery system
of the derby hat branched stent-graft, the procedure was complete. Repeat
angiography was recommended to confirm both the position and the shape
of the Yanger stent-graft system and to determine whether any valvular
insufficiency, endoleak, brachiocephalic branch, or coronary artery
obstruction was present (Figure 4, I). The whole angiography procedure1206 The Journal of Thoracic and Cardiovascular Surof total endovascular stent-graft implantation into the aortic arch is
presented in Video 1.
After stent-graft implantation, all experimental animals received
postoperative intramuscular injections of penicillin and subcutaneous
injections of low molecular weight heparin (2500 IU) for 3 days. The
animals were bred for 6 months in an environment with a temperature of
15C to 25C and a humidity of 40%, and received food and water 3 times
daily. Oral aspirin (3 mg/kg of body weight) was administered for 30
consecutive days.
After successful stent-graft implantation, 2 animals were euthanized at
1 hour and 1 month, respectively, for stent-graft retrieval and histologic
evaluation. The covered stent-graft was carefully removed from the aortic
arch, and the surface of the stent-graft was examined via pathologic
sectioning and scanning electron microscopy.gery c April 2016
FIGURE 3. An in vitro test of the Yanger stent-graft system. A, Twowires were preloaded. B, The delivery system and compressed primary stent-graft were
advanced into the aortic arch. C, The compressed branch was retracted into the BCT, and the distal portion of the stent-graft was opened. D, The branch of the
primary stent-graft was released. E, A super-slippery wire/stiff-wire was introduced into the LSCA. F, The delivery system of the derby hat branched
stent-graft was advanced into the LSCA. G, The branched stent-graft was released. H, Total endovascular aortic arch reconstruction was complete.
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The dietary habits, health, mental status, and bowel activities of the
animals were observed after surgery and during a 6-month follow-up
period. At 6 months after stent-graft implantation, transthoracic color
Doppler was used to evaluate the animals’ ejection fractions, as well as
the degree of aortic regurgitation, left ventricular volume change, degree
of stenosis within any part of the graft, and blood flow velocity changes
of each brachiocephalic artery. Multislice computed tomography
(MSCT) was performed with appropriate contrast to assess the shape,
location, and hemodynamic status of the stent-graft.
Statistical Analysis
Data were presented as means  standard deviations, medians with
ranges, or frequencies or percentages, as appropriate. SPSS 16.0 for
Windows (SPSS, Inc, Chicago, Ill) was used for the statistical analysis.
The t test, chi-square test, and Fisher exact test were used for comparisons
between 2 groups, where appropriate.
RESULTS
In Vitro Test Results
Six sets of the Yanger stent-graft system were tested
using an in vitro aortic arch simulation test bench, a testThe Journal of Thoracic and Carthat was repeated 5 times (2 sets each of 24-20-160 mm,
28-24-160 mm, and 32-26-160 mm). A total of 30 in vitro
tests were performed. Stent-graft release was successful
during each of the 30 tests. However, 14 instances of branch
wire entanglement with the Lunderquist super-stiff
guidewire were noted. All entanglements were successfully
resolved via clockwise rotation of the primary stent-graft
delivery system. The branch delivery system was deployed
through the fenestration during all tests, and the final
position of each graft was satisfactory.Intraoperative Results and Clinical Follow-up
Fourteen of the 16 animals underwent stent-graft
implantation. Two deaths occurred periprocedurally. One
animal died of peripheral vascular complications, and 1 an-
imal died of an intraoperative arrhythmia when the external
sheath was introduced into aortic arch. Ventricular fibrilla-
tion was most likely triggered via hemodynamic instability.
Anatomic parameters were measured via angiography anddiovascular Surgery c Volume 151, Number 4 1207
FIGURE 4. The release procedure of the Yanger stent-graft system in a canine model. A, The delivery system and compressed main stent-graft were
advanced into the aortic arch. B, The compressed branch was retracted into the BCT. C, The distal portion of the primary stent-graft was opened.
D, The branch of the primary stent-graft was released, and the front fixation of the primary stent-graft was opened. E, Ascending aortography demonstrated
that the primary body of the Yanger stent-graft system was successfully released, without obstructing brachiocephalic branches. F, A stiff-wire was
introduced into the LSCA. G, The delivery system of the derby hat branched stent-graft was advanced into the LSCA. H, After retrieving the outer sheath,
retracting the prebonded thread, and retrieving the delivery system of the derby hat branched stent-graft, the procedure was complete. I, Repeat angiography
demonstrated excellent positioning and shaping of the Yanger stent-graft system, as well as patent brachiocephalic branches and evidence of valvular
insufficiency, endoleak, or coronary artery obstruction.
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11.7  1.1 mm via angiography and 11.4  1.2 mm via
Doppler ultrasound. The diameters of the LSCA, ascending
aorta, and descending aorta were 9.5  0.8 mm,
25.3  2.0 mm, and 18.9  1.3 mm, respectively, via
angiography. The distance between the BCT and the
LSCA was 6.5  1.1 mm, and the distance between the
BCT and the annulus was 44.7  3.9 mm. The mean
x-ray exposure time was 18.3  1.8 minutes. The mean1208 The Journal of Thoracic and Cardiovascular Surduration of the procedure was 101.7  13.1 minutes
(Table 1). No obvious endoleak was noted in all animals
using angiography. Blood pressures, including systolic,
diastolic, and mean pressures, were measured and recorded
using a multipurpose catheter within the ascending aorta,
descending aorta, distal to the BCT, and distal to the
LSCA. No significant differences were noted (Figure 5).
At 6 months of follow-up, no evidence of persistent atrio-
ventricular block or ventricular arrhythmia was observed.gery c April 2016
TABLE 1. Baseline characteristics and procedural data of the animals
that underwent endovascular aortic arch reconstruction (means ±
standard deviations)
Dogs (n) 16
Sex (F/M) (n/%) 7 (43.8%)/9 (56.2%)
Age (y) 2.1  0.3
Weight (kg) 28.2  2.7
Diameter of BCT (mm) 11.7  1.1
Distance between BCT and LSCA (mm) 6.5  1.1
Diameter of LSCA (mm) 9.5  0.8
Diameter of ascending aorta (mm) 25.3  2.0
Diameter of descending aorta (mm) 18.9  1.3
Distance between BCT and annulus (mm) 44.7  3.9
X-ray exposure time (min) 18.3  9.8
Operation time (min) 101.7  13.1
BCT, Brachiocephalic trunk; LSCA, left subclavian artery.
Yang et al Evolving Technology: AortaNo significant occlusion or stenosis of the brachiocephalic
branches was observed at 6 months of follow-up. There
was no stent fracture or stent-graft migration by MSCT
examination in all surviving animals at the 6-month
follow-up. No paraplegia was found in our animal study
series.
Gross Anatomic and Histopathologic Examinations
The macroscopic findings at autopsy demonstrated that
the Yanger stent-graft was successfully deployed within
the aorta; no crevices between the stent-graft and the
native aorta were observed. At 1 month of follow-up, a
macroscopic analysis demonstrated that the device was inFIGURE 5. Blood pressure measurements at different positions pre- and post
D, Descending aorta.
The Journal of Thoracic and Carthe appropriate position and partially covered with endothe-
lium. The position was consistent with the MSCT images.
No macroscopic damage, including the erosion of atrial
wall, was noted in the native aortas of individual animals.Multislice Computed Tomography and
Echocardiographic Evaluations
The computed tomography angiography images demon-
strated that the stent-grafts were in excellent position, with
the proximal and distal portions located within the
ascending and descending aortas, respectively. An axial
scan demonstrated patent BCT and LSCA vasculature via
stent-graft images of the arch, ascending aorta, and
descending aorta (Figure 6).
Three-dimensional reconstruction MSCT images de-
picted the stent-graft at an appropriate position (Figure 7).
The ascending aorta, descending aorta, BCT, and LSCA
were each covered by the Yanger stent-graft system. There
was no obstruction or stenosis noted in the brachiocephalic
branches. No endoleak was observed between the stent-
graft system and the native aortic wall. Echocardiographic
imaging also demonstrated that the stent-grafts were in an
appropriate position at 6 months of follow-up. MSCT after
total endovascular stent-graft implantation into the aortic
arch in canine models is shown in Videos 2-4.DISCUSSION
Aneurysms and dissections involving the ascending aorta
and arch historically have been treated through opensurgery. A, Ascending aorta. B, Distal to the BCT. C, Distal to the LSCA.
diovascular Surgery c Volume 151, Number 4 1209
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FIGURE 6. Axial MSCT images after the deployment of the Yanger stent-graft system. A, Brachiocephalic branch level. B, Arch level. C, Descending
aortic level. D, Sinotubular junction level.
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Tsurgical techniques requiring cardiopulmonary bypass and
under deep hypothermic circulatory arrest.11,14,15 Despite
continued refinements to these procedures, these
procedures are still associated with substantial mortality
and morbidity, particularly among the elderly.16 Since the
invention of the endovascular procedure by Parodi17 to treat
aortic aneurysms, both endovascular abdominal aneurysm
repair and TEVAR have gained recognition as alternatives
to conventional surgical repair in the treatment of various
aortic morphologies.18,19 Although it is not the standard
care for retrograde dissection and arch pathology, TEVAR
and other surgical procedures as debranching techniques
have been used to treat retrograde extension into the arch
and ascending aorta, because coverage of the entry site is
needed to induce aortic remodeling and healing.20-22
However, these hybrid approaches are not recommended
as the first option in the treatment of aortic arch lesions.
Experience gained from endovascular abdominal aneu-
rysm repair and recent advances in branch and fenestrated
stent-grafts in the treatment of abdominal aortic aneurysms
have made the treatment of more complex anatomy
possible.23-25 Fenestrated endografts, the chimney
technique, and in situ fenestration also have become
options for endovascular aortic arch repair.26-29 Among
these techniques, the endograft manufactured by Cook Inc
seems to be the most promising. Preliminary human
studies have confirmed both the short-term safety and the1210 The Journal of Thoracic and Cardiovascular Sureffectiveness of this system.28,29 However, this system and
other fenestrated/branched stent-grafts do not allow for
anatomic adaption to the native curvature of the arch and
brachiocephalic vessels.
On the basis of the previous design of the branched
stent-graft, as well as other techniques,30,31 we designed a
new stent-graft system with the assistance of the research
and engineering staff of LifeTech Scientific. The Yanger
stent-graft system is designed to fully adapt to the native
anatomy of the aortic arch, which contrasts with previous
designs. The in vitro tests performed during our study
demonstrated the effectiveness of the system’s release.
We also demonstrated the technical feasibility of
endovascular treatment of the aortic arch using a simplified
branched stent-graft in a canine model. The Yanger
stent-graft system was implanted with each of the
supra-arch branches preserved and protected. On the basis
of our experience, to achieve satisfactory results, several
crucial steps should be taken into consideration. First and
foremost, avoiding entanglements between the branch
wire and the Lunderquist super-stiff guidewire is essential.
Clockwise rotation of the primary stent-graft delivery
system allows for resolution of the entanglement, both
in vitro and in an animal model. Second, femoral arteries
of dogs are relatively small and do not represent good entry
points for the stent-graft system. Laparotomy and the
abdominal artery are recommended as entry points to avoidgery c April 2016
FIGURE 7. Three-dimensional reconstruction MSCT images after the deployment of the Yanger stent-graft system at 6 months of follow-up. A, Sagittal
view of dog 3. B, Reconstruction image of dog 3. C, Reconstruction image of dog 9. D, Reconstruction image of dog 9, frontal view. E, Reconstruction image
of dog 9, rear view. F, Reconstruction image of dog 15.
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of the canine BCT made it difficult to insert the cannula.
Simultaneous stretching of both ends of the guidewire
may help the catheters advance through the BCT. The
prevention of embolic cerebrovascular accidents is an
additional consideration. The release of the branch
stent-graft of the BCT and LSCA was performed via the
transfemoral retrograde approach in our study. No sheath
was necessary to enter the BCT and LSCA, which
significantly reduced the incidence of embolic cerebrovas-
cular events. In our animal experiments, our stent-graft
implantation technique appeared to be safe with respects
to the risk of an embolic cerebrovascular event.
Study Limitations
Our preclinical study suffered from several limitations.
First and foremost, the canine model offers only a partial
simulation of native human anatomy. The anatomic
variations found among humans are far more complex
than those in canine models. Second, the canine model is
a physiologic model and does not allow for the mimicry
of dissection or aneurysm. Third, the long-term durability
of the branched stent-grafts in aortic arch is unknown.
Therefore, long-term follow-up is necessary to address
this issue. Finally, the devices were not individualized.
Thus, the stent-graft may be too small or too large.The Journal of Thoracic and CarCONCLUSIONS
With the use of a canine model, our study demonstrated
both the safety and the efficacy of the Yanger stent-graft
system, which has been successfully implanted in an appro-
priate and stable position, and patent brachiocephalic flow
was also demonstrated. The ascending aorta, aortic arch,
BCT, LSCA, and descending aorta were each protected by
the endograft. The application of this graft system for
the total endovascular repair of the aortic arch is both
feasible and reliable. Theoretically, the application of this
technique may be expanded to a wide range of therapies
involving the ascending aorta and the aortic arch using
individualized devices. The ethics committee of Xijing
Hospital has approved the device for limited clinical
use (KY20141017-1); this trial is registered with
ClinicalTrials.gov (NCT01496833 TEARS study). With
increasing preclinical knowledge, both patient selection
criteria and the first in-human studies will be addressed.
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